Saving changes...

Done

Error

Medicaid Coverage of Medications to Treat Alcohol and Opioid Use Disorders

Medicaid Coverage of Medications to Treat Alcohol and Opioid Use Disorders

Medicaid Coverage of Medications to Treat Alcohol and Opioid Use Disorders

Industry Specialist
Industry Specialist
on behalf of Quantum Units Education

$80.00 $ 80.00 $ 80.00

$80.00 $ 80.00 $ 80.00

$ 80.00 $ 80.00 $ 80.00
$ 80.00 $ 80.00 $ 80.00
Normal Price: $80.00 $80.00

Review:

Launch date: 01 Feb 2018
Expiry Date:

Last updated: 06 Aug 2018

Reference: 186811

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This course describes treatment effectiveness, cost effectiveness, current coverage under each Medicaid program, and examples of innovative financing and delivery models used by states to provide disulfiram, acamprosate, methadone, buprenorphine, buprenorphine-naloxone, and naltrexone to those with alcohol and/or opioid use disorders.

*This course is not approved for NBCC renewal.

Objectives

On completion of this course, the learner will be able to:
1. Enumerate the three drugs with the least coverage across Medicaid programs for the purpose of treating opioid addiction and explain why this is seen.

2. Investigate what the scientific research has found for the benefits that medications for alcohol and opioid dependence provide to the client and to the rest of society.

3. Compare and contrast the different medications used for alcohol and opioid dependence and explain how each produces the desired results.

4. Examine the five controlled substance schedules defined under the Controlled Substances Act.

5. Identify who may dispense methadone or buprenorphine to a patient under the direction of the OTP medical director who is certified by SAMHSA and registered with the DEA, as long as the activity is consistent with state law.
Industry Specialist

Author Information Play Video Bio

Industry Specialist
on behalf of Quantum Units Education

Quantum Units Education began in 2005 with a vision: to be a company with a conscience. Quantum Units Education is not your ordinary CE provider. What this means is simple: we strive to give back. We are grateful for the opportunity we have been given to help others. We want to pay it forward in caring for the environment and our community - which includes each and every customer that crosses our path. We are all in relationship with each other and with our planet. Let us think bigger, take action that creates lasting change, be innovative with our use of green technologies, engage with like-minded partners and move responsibly in our global community.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • California Board of Registered Nursing (CBRN)
  • 4.00 Hours
  • Florida Board of Nursing
  • 4.00 Hours -
    Exam Pass Rate: 70

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error